Organogenesis Holdings Inc.
ORGO
$4.69
-$0.195-4.00%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -37.77% | 172.35% | -711.57% | -269.72% | -117.94% |
| Total Depreciation and Amortization | 1.02% | 4.86% | 5.71% | -5.67% | 11.64% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -3.68% | -76.90% | 190.08% | -9.93% | 42.09% |
| Change in Net Operating Assets | 51.05% | -83.17% | 63.48% | -680.62% | -187.73% |
| Cash from Operations | 25.78% | 83.52% | 146.62% | -195.74% | -36.57% |
| Capital Expenditure | -30.83% | -36.65% | 15.39% | 33.15% | 44.41% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -30.83% | -36.65% | 15.39% | 33.15% | 44.41% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -3,623.01% | -0.54% | -0.30% | 6.19% | -23.73% |
| Issuance of Common Stock | 21,160.00% | -- | -100.00% | 17,900.00% | -- |
| Repurchase of Common Stock | -- | -- | 95.18% | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 2,106.50% | 2.90% | 33.78% | -46.76% | -23.57% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 826.61% | 293.37% | 107.54% | -371.94% | -40.83% |